ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
64 hedge funds and large institutions have $82.5M invested in Oncternal Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
51% less call options, than puts
Call options by funds: $1.41M | Put options by funds: $2.85M
Holders
64
Holding in Top 10
–
Calls
$1.41M
Puts
$2.85M
Top Buyers
| 1 | +$7.97M | |
| 2 | +$6.1M | |
| 3 | +$3.95M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.62M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$3.34M |
Top Sellers
| 1 | -$4.74M | |
| 2 | -$3.57M | |
| 3 | -$1.96M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.78M |
| 5 |
EP
Eversept Partners
New York
|
-$1.69M |